Evidence map›Paper›PMID 41648515›Full record

ArticlebioRxiv : the preprint server for biology2026

cloneXplorer: A high-throughput clone discovery platform based on conical microwell arrays.

Guido K Stadler, Eugene Tkachenko, Oscar Neri, Michael Zakharov, Orr Zohar, Debbie X Deng, Kitt D Paraiso, Hajar Rajaei, Shaun Steele, Xiling Shen and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guido K StadlerCelldom, Inc., 733 Industrial Rd, San Carlos, CA 94070.
Eugene TkachenkoCelldom, Inc., 733 Industrial Rd, San Carlos, CA 94070.
Oscar NeriCelldom, Inc., 733 Industrial Rd, San Carlos, CA 94070.
Michael ZakharovCelldom, Inc., 733 Industrial Rd, San Carlos, CA 94070.
Orr ZoharStanford University, Department of Electrical Engineering, Stanford, CA 94305.
Debbie X DengCellecta, Inc., 320 Logue Ave. Mountain View, CA 94043.
Kitt D ParaisoCellecta, Inc., 320 Logue Ave. Mountain View, CA 94043.
Hajar RajaeiMD Anderson, Gastrointestinal Medical Oncology, The UT MD Anderson Cancer Center, Houston, TX 77030.
Shaun SteeleMD Anderson, Gastrointestinal Medical Oncology, The UT MD Anderson Cancer Center, Houston, TX 77030.
Xiling ShenMD Anderson, Gastrointestinal Medical Oncology, The UT MD Anderson Cancer Center, Houston, TX 77030.
Alex ChenchikCellecta, Inc., 320 Logue Ave. Mountain View, CA 94043.
Benjamin B YellenCelldom, Inc., 733 Industrial Rd, San Carlos, CA 94070.

Funding

Robust Control of the Stem Cell NicheR35GM122465 · NIGMS · TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION · PI Xiling Shen · 2017 to 2026
$5.6M
High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-culturesR44CA281575 · NCI · CELLDOM, INC. · PI YELLEN, BENJAMIN BIRON · 2024 to 2025
$1.8M
NCI NIH HHS R44 CA281575NIGMS NIH HHS R35 GM122465
6 · The paper itself

Abstract

Antigen-specific T cell populations are of great value for studying immune recognition but tedious to generate by limiting dilution or cloning. Here, we develop a streamlined approach to generate antigen-specific T cell clones directly from peripheral blood using the cloneXplorer, a live-cell analysis and clone isolation platform based on conical microwell arrays. This platform continuously monitors cell proliferation, cytokine secretion, and surface markers in up to 100,000 single cell co-cultures, enabling the identification of rare, functionally defined T cells, which can be recovered for clonal expansion or sequence analysis. We benchmark the platform by performing several key demonstrations. First, we show that this platform can efficiently generate monoclonal cell populations from cell lines and human T cells. Next, we demonstrate that antigen-specificity can be identified at single cell resolution using a co-culture of Jurkat cells expressing NFAT-GFP, CD8, and a T cell receptor and K562 antigen presenting cells (APC) expressing a peptide library. Thereafter, we show that immune activation in mouse and human primary samples can be monitored by time lapse analysis of Interferon gamma (IFN-γ) secretion in individual microwell co-cultures using a fluorescent sandwich assay. Finally, we combine these capabilities in a proof-of-concept demonstration, which uses IFN-γ secretion and the presence of CD8 surface markers as hierarchical gates to isolate and expand antigen-specific T cells from human peripheral blood, and we verify their specificity by tetramer staining. Together, these results showcase potential applications of the cloneXplorer platform in cell line development, and in screening and validating immune receptor interactions with specific antigens.

Identifiers

PMID41648515
PMCPMC12871585

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.